LXRX
Price
$1.25
Change
+$0.01 (+0.81%)
Updated
Jan 15, 12:37 PM (EDT)
Capitalization
450.61M
62 days until earnings call
Intraday BUY SELL Signals
NMRA
Price
$2.06
Change
-$0.09 (-4.19%)
Updated
Jan 15, 11:54 AM (EDT)
Capitalization
367.07M
55 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LXRX vs NMRA

Header iconLXRX vs NMRA Comparison
Open Charts LXRX vs NMRABanner chart's image
Lexicon Pharmaceuticals
Price$1.25
Change+$0.01 (+0.81%)
Volume$220
Capitalization450.61M
Neumora Therapeutics
Price$2.06
Change-$0.09 (-4.19%)
Volume$3.79K
Capitalization367.07M
LXRX vs NMRA Comparison Chart in %
LXRX
Daily Signal:
Gain/Loss:
NMRA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LXRX vs. NMRA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LXRX is a Hold and NMRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (LXRX: $1.24 vs. NMRA: $2.15)
Brand notoriety: LXRX and NMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LXRX: 92% vs. NMRA: 41%
Market capitalization -- LXRX: $450.61M vs. NMRA: $367.07M
LXRX [@Biotechnology] is valued at $450.61M. NMRA’s [@Biotechnology] market capitalization is $367.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LXRX’s FA Score shows that 1 FA rating(s) are green whileNMRA’s FA Score has 1 green FA rating(s).

  • LXRX’s FA Score: 1 green, 4 red.
  • NMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, NMRA is a better buy in the long-term than LXRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LXRX’s TA Score shows that 5 TA indicator(s) are bullish while NMRA’s TA Score has 3 bullish TA indicator(s).

  • LXRX’s TA Score: 5 bullish, 3 bearish.
  • NMRA’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, LXRX is a better buy in the short-term than NMRA.

Price Growth

LXRX (@Biotechnology) experienced а +5.98% price change this week, while NMRA (@Biotechnology) price change was -6.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

LXRX is expected to report earnings on Mar 18, 2026.

NMRA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LXRX($451M) has a higher market cap than NMRA($367M). NMRA YTD gains are higher at: 20.112 vs. LXRX (7.826). LXRX has higher annual earnings (EBITDA): -57.78M vs. NMRA (-254.48M). NMRA has more cash in the bank: 172M vs. LXRX (116M). NMRA has less debt than LXRX: NMRA (20.1M) vs LXRX (58.2M). LXRX has higher revenues than NMRA: LXRX (70.9M) vs NMRA (0).
LXRXNMRALXRX / NMRA
Capitalization451M367M123%
EBITDA-57.78M-254.48M23%
Gain YTD7.82620.11239%
P/E RatioN/AN/A-
Revenue70.9M0-
Total Cash116M172M67%
Total Debt58.2M20.1M290%
FUNDAMENTALS RATINGS
LXRX: Fundamental Ratings
LXRX
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LXRXNMRA
RSI
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 8 days ago
88%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
LXRX
Daily Signal:
Gain/Loss:
NMRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPSX29.130.76
+2.68%
ProFunds Pharmaceuticals UltraSector Svc
PCHSX35.340.37
+1.06%
Putnam Global Health Care C
DHIIX21.740.17
+0.79%
Diamond Hill International I
JGMRX23.180.16
+0.70%
Janus Henderson Triton R
AWTCX17.950.08
+0.45%
Virtus Duff & Phelps Water C

NMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMRA has been loosely correlated with VTYX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if NMRA jumps, then VTYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMRA
1D Price
Change %
NMRA100%
+0.47%
VTYX - NMRA
41%
Loosely correlated
N/A
NGNE - NMRA
38%
Loosely correlated
+10.91%
AURA - NMRA
36%
Loosely correlated
+3.95%
SNDX - NMRA
35%
Loosely correlated
+4.74%
LXRX - NMRA
33%
Loosely correlated
+3.33%
More